These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22491045)

  • 1. Anal Carcinoma, Version 2.2012: featured updates to the NCCN guidelines.
    Benson AB; Arnoletti JP; Bekaii-Saab T; Chan E; Chen YJ; Choti MA; Cooper HS; Dilawari RA; Engstrom PF; Enzinger PC; Fakih MG; Fleshman JW; Fuchs CS; Grem JL; Leong LA; Lin E; May KS; Mulcahy MF; Murphy K; Rohren E; Ryan DP; Saltz L; Sharma S; Shibata D; Skibber JM; Small W; Sofocleous CT; Venook AP; Willett C; Freedman-Cass DA;
    J Natl Compr Canc Netw; 2012 Apr; 10(4):449-54. PubMed ID: 22491045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of positron emission tomography-computed tomography in the management of anal cancer.
    Mistrangelo M; Pelosi E; Bellò M; Ricardi U; Milanesi E; Cassoni P; Baccega M; Filippini C; Racca P; Lesca A; Munoz FH; Fora G; Skanjeti A; Cravero F; Morino M
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):66-72. PubMed ID: 22592047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between pelvic MRI, CT, and PET/CT in baseline staging and radiation planning of anal squamous cell carcinoma.
    Horvat N; Jayaprakasam VS; Crane CH; Zheng J; Gangai N; Romesser PB; Golia Pernicka JS; Capanu M; Gollub MJ
    Abdom Radiol (NY); 2024 May; 49(5):1351-1362. PubMed ID: 38456896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anal Carcinoma, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
    Benson AB; Venook AP; Al-Hawary MM; Azad N; Chen YJ; Ciombor KK; Cohen S; Cooper HS; Deming D; Garrido-Laguna I; Grem JL; Hecht JR; Hoffe S; Hubbard J; Hunt S; Hussan H; Jeck W; Johung KL; Joseph N; Kirilcuk N; Krishnamurthi S; Maratt J; Messersmith WA; Meyerhardt J; Miller ED; Mulcahy MF; Nurkin S; Overman MJ; Parikh A; Patel H; Pedersen K; Saltz L; Schneider C; Shibata D; Skibber JM; Sofocleous CT; Stotsky-Himelfarb E; Tavakkoli A; Willett CG; Williams G; Algieri F; Gurski L; Stehman K
    J Natl Compr Canc Netw; 2023 Jun; 21(6):653-677. PubMed ID: 37308125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anal carcinoma: FDG PET/CT in staging, response evaluation, and follow-up.
    Saboo SS; Zukotynski K; Shinagare AB; Krajewski KM; Ramaiya N
    Abdom Imaging; 2013 Aug; 38(4):728-35. PubMed ID: 23011550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
    Benson AB; Venook AP; Al-Hawary MM; Cederquist L; Chen YJ; Ciombor KK; Cohen S; Cooper HS; Deming D; Engstrom PF; Grem JL; Grothey A; Hochster HS; Hoffe S; Hunt S; Kamel A; Kirilcuk N; Krishnamurthi S; Messersmith WA; Meyerhardt J; Mulcahy MF; Murphy JD; Nurkin S; Saltz L; Sharma S; Shibata D; Skibber JM; Sofocleous CT; Stoffel EM; Stotsky-Himelfarb E; Willett CG; Wuthrick E; Gregory KM; Freedman-Cass DA
    J Natl Compr Canc Netw; 2018 Jul; 16(7):852-871. PubMed ID: 30006428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography/computed tomography in the staging and treatment of anal cancer.
    Sveistrup J; Loft A; Berthelsen AK; Henriksen BM; Nielsen MB; Engelholm SA
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):134-41. PubMed ID: 22000745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Definitive chemoradiotherapy for anal canal cancer: single-center experience.
    Tachibana I; Nishimura Y; Inada M; Fukuda K; Ishikawa K; Nishikawa T; Yokokawa M; Nakamatsu K; Kanamori S; Hida JI
    Int J Clin Oncol; 2018 Dec; 23(6):1121-1126. PubMed ID: 29992389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of FDG-PET in the Initial Staging and Response Assessment of Anal Cancer: A Systematic Review and Meta-analysis.
    Jones M; Hruby G; Solomon M; Rutherford N; Martin J
    Ann Surg Oncol; 2015 Oct; 22(11):3574-81. PubMed ID: 25652048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. F-18 FDG PET/CT imaging of anal canal squamous cell carcinoma.
    Nguyen BD; Ram PC; Roarke MC
    Clin Nucl Med; 2007 Mar; 32(3):234-6. PubMed ID: 17314608
    [No Abstract]   [Full Text] [Related]  

  • 11. Contrast-enhanced [(18)F]fluorodeoxyglucose-positron emission tomography/computed tomography for staging and radiotherapy planning in patients with anal cancer.
    Bannas P; Weber C; Adam G; Frenzel T; Derlin T; Mester J; Klutmann S
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):445-51. PubMed ID: 20832181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron Emission Tomography for pretreatment staging and posttreatment evaluation in cancer of the anal canal.
    Trautmann TG; Zuger JH
    Mol Imaging Biol; 2005; 7(4):309-13. PubMed ID: 16028002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of Nonadherence to NCCN Guideline Recommendations for the Management of Stage I Anal Canal Cancer.
    Kole AJ; Stahl JM; Park HS; Khan SA; Johung KL
    J Natl Compr Canc Netw; 2017 Mar; 15(3):355-362. PubMed ID: 28275036
    [No Abstract]   [Full Text] [Related]  

  • 14. Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome.
    Milano MT; Jani AB; Farrey KJ; Rash C; Heimann R; Chmura SJ
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):354-61. PubMed ID: 16168830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDG-PET/CT: new horizons in anal cancer.
    Grigsby PW
    Gastroenterol Clin Biol; 2009 May; 33(5):456-8. PubMed ID: 19394179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of inguinal node metastases in patients with anal cancer.
    Mistrangelo M; Pelosi E; Bellò M; Castellano I; Cassoni P; Ricardi U; Munoz F; Racca P; Contu V; Beltramo G; Morino M; Mussa A
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):73-8. PubMed ID: 19632066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging of Anal Squamous Cell Carcinoma: Survey Results and Expert Opinion from the Rectal and Anal Cancer Disease-Focused Panel of the Society of Abdominal Radiology.
    Golia Pernicka JS; Rauch GM; Gangai N; Bates DDB; Ernst R; Hope TA; Horvat N; Sheedy SP; Gollub MJ
    Abdom Radiol (NY); 2023 Sep; 48(9):3022-3032. PubMed ID: 36932225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the impact of FDG-PET in the management of anal cancer.
    Nguyen BT; Joon DL; Khoo V; Quong G; Chao M; Wada M; Joon ML; See A; Feigen M; Rykers K; Kai C; Zupan E; Scott A
    Radiother Oncol; 2008 Jun; 87(3):376-82. PubMed ID: 18453023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG PET/CT in the management of colorectal and anal cancers.
    Agarwal A; Marcus C; Xiao J; Nene P; Kachnic LA; Subramaniam RM
    AJR Am J Roentgenol; 2014 Nov; 203(5):1109-19. PubMed ID: 25341152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022.
    Schmults CD; Blitzblau R; Aasi SZ; Alam M; Andersen JS; Baumann BC; Bordeaux J; Chen PL; Chin R; Contreras CM; DiMaio D; Donigan JM; Farma JM; Ghosh K; Grekin RC; Harms K; Ho AL; Holder A; Lukens JN; Medina T; Nehal KS; Nghiem P; Park S; Patel T; Puzanov I; Scott J; Sekulic A; Shaha AR; Srivastava D; Stebbins W; Thomas V; Xu YG; McCullough B; Dwyer MA; Nguyen MQ
    J Natl Compr Canc Netw; 2021 Dec; 19(12):1382-1394. PubMed ID: 34902824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.